A company insider recently sold 5,000 shares of Cytokinetics Inc [CYTK]. Should You Sale?
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Cytokinetics Inc’s recently made public that its EVP Research & Development Malik Fady Ibraham unloaded Company’s shares for reported $0.37
In a filing, Cytokinetics Inc revealed its President & CEO Blum Robert I unloaded Company’s shares for reported $0.26 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Cytokinetics Inc revealed its President & CEO Blum Robert I unloaded Company’s shares for reported $0.26 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Cytokinetics Inc’s filing revealed that its Director WENDELL WIERENGA acquired Company’s shares for reported $0.23 million on Oct 28 ’24.
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cytokinetics Inc
Cytokinetics Inc’s recent filing unveils that its EVP Research & Development Malik Fady Ibraham unloaded Company’s shares for reported $0.4
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.